| Similar Articles |
|---|
 |
The Motley Fool
November 22, 2006
Brian Lawler |
Implant Approval Gives Allergan a Lift The return of silicone breast implants continues. Shares of Allergan, best known for its Botox wrinkle treatment, were up nearly 8% on the news.   |
The Motley Fool
January 23, 2004
Jean Graham |
Keeping Abreast of Implants Inamed's race with Mentor for first rights to the silicone breast implant market hits a snag. |
The Motley Fool
May 19, 2006
Jim Mueller |
Foolish Forecast: Mentor's Uncertain Results Factors outside of the cosmetic surgery products maker's control are leading to short-term uncertainty. Investors, take note. |
BusinessWeek
April 25, 2005
Catherine Arnst |
Breast Implants: Science vs. Emotion Lobbying and politics are having a huge effect on the debate over whether to allow silicone breast implants back on the market. |
The Motley Fool
April 14, 2005
Rich Duprey |
Mentor the Winner on Implants An FDA panel gives Mentor the right to market breast implants after denying Inamed's application. On the news, Inamed's stock fell by more than 3%, and then nearly 7% in early morning trading. |
The Motley Fool
March 21, 2005
Rich Duprey |
Inamed Buoyant on Medicis Buyout Breast-implant maker Inamed will be acquired in a $2.8 billion deal with skin-care pharmaceutical Medicis. Inamed investors should now decide whether they want to be a part of Medicis or enjoy the profits realized from the offer. |
The Motley Fool
February 9, 2006
Stephen D. Simpson |
Mentor Needs Some Prettying Up Until new products are approved or acquired, the aesthetics and urology company seems stuck in suspended animation. Just standing in place is not going to build much shareholder value. |
Chemistry World
August 1, 2006
Victoria Gill |
Breast Implant Study `Probably Flawed' The editors of a journal that published a study linking silicone breast implants with higher than normal levels of platinum in the circulation have urged caution when interpreting the findings. |
The Motley Fool
March 2, 2011
Susmita Chatterjee |
How to Capitalize on the Obesity Epidemic Does broader use of Allergan's Lap-Band signify competition for others? |
The Motley Fool
August 8, 2006
Stephen D. Simpson |
Waiting on Fine Figures From Mentor Flush with cash, medical aesthetics specialist Mentor needs to reinvest in growth. This is a fine company that rarely trades cheap -- investors, take note. |
BusinessWeek
December 25, 2006
Palmeri & Weintraub |
Silicone Goes Subtle Allergan's campaign relies on friendly persuasion. |
BusinessWeek
March 25, 2010
Elizabeth Lopatto |
And Now, Gastric Surgery for Kids Allergan wants to market its Lap-Band implants for younger obese patients, but some doctors are balking |
The Motley Fool
January 31, 2007
Brian Lawler |
No Earnings Face-Lift Needed For Allergan The ophthalmic and plastic surgery product developer has made many investors rich, and it's not stopping now. |
The Motley Fool
June 3, 2004
Mark Mahorney |
Breast Enhancer Bounces Back Dow Corning emerges from bankruptcy after nine years spent protecting itself from several hundred thousand suing women who claimed that ruptured silicone breast implants made by the company were the cause of autoimmune diseases. Now what? |
The Motley Fool
February 25, 2008
Brian Lawler |
A Positive Surprise for Genentech Biopharma Genentech's lead drug gets a conditional OK to treat breast cancer. |
Salon.com
October 9, 2000
Denise Dowling |
Covering up the breast The National Cancer Institute decides not to publicize the results of a publicly funded study of the safety of silicone breast implants. What's the deal? |
The Motley Fool
December 16, 2005
Stephen D. Simpson |
A Romantic Rectangle in Health Care First Medicis wants Inamed, then Allergan wants Inamed. Now Mentor wants Medicis. Strange days in health care, to be sure. Investors, take note. |
BusinessWeek
April 25, 2005
Catherine Arnst |
When Patients Say: Don't Ban My Drug Emotional lobbying can keep a treatment on the market despite serious side effects. |
The Motley Fool
December 31, 2010
Brian Orelli |
2010 FDA Approvals and a Look Ahead Recent history can help us handicap FDA decisions. |
The Motley Fool
April 6, 2005
Stephen D. Simpson |
Investing in Controlling Obesity While every investor must do their own due diligence, here is an outline of at least some of the major ways that investors can hope to profit from medical technology aimed at curing, or at least controlling, obesity.. |
Health
January 5, 2010
Susan Hall |
Thinking About Cosmetic Surgery? Here's How to Get a Better Nip or Tuck We reveal what it's like to have the three most popular procedures and whether those money-saving alternatives people talk about are worth it. |
The Motley Fool
January 28, 2011
Brian Orelli |
Value Investing, Biotech Style Biotech investors should regard every binary event as a varying degree of confidence in a positive or negative result. |
The Motley Fool
February 16, 2010
Brian Orelli |
For Blockbuster Cancer Drugs, Approvals Are the Easy Part Don't get too excited. As an investor, you can lower your risk by investing in cancer drug companies after a clinical trial success but before an FDA approval, but you'll also reduce your reward. |
HBS Working Knowledge
August 10, 2015
Michael Blanding |
New Medical Devices Get To Patients Too Slowly The FDA has streamlined drug testing to ensure new therapies come to market quickly. But when it comes to life-giving medical devices, approvals seem unnecessarily slow, according to research by Ariel Dora Stern. |
IndustryWeek
October 19, 2011 |
FDA: A Future Innovation Partner? Could the Food and Drug Administration reform itself to help manufacturers create new medical technologies? |
Food Processing
August 2009 |
MRO Q&A: Do any FDA regulations prohibit the use of 100 percent silicone sealers to be used in the sealing of various surfaces/joints in a food plant? Welcome to a Food Processing series addressing maintenance, repair and operational issues in food plants. We've assembled a panel of plant operations experts to answer any question you have on plant-floor issues. |
AskMen.com
Austin Silver |
Celebrities & Cosmetic Surgery What is happening in today's society? It seems that the most fashionable thing among celebrities is plastic surgery. Everything from tummy tucks and chin implants to eye lifts and breast implants have taken effect more than ever. |
Salon.com
March 2, 2001
Dawn MacKeen |
Your heart has been recalled In the brave new world of body-part implants, what happens when you get a lemon of a ticker? |
AskMen.com
Dustin Driver |
Male Plastic Surgery If you're thinking about surgical body modifications, keep reading. The following procedures can be performed in a matter of hours by a skilled plastic surgeon. |
The Motley Fool
December 22, 2003
Alyce Lomax |
Losing Faith in Inspire Delay for its dry-eye treatment leaves investors uninspired. |
The Motley Fool
August 17, 2007
Brian Orelli |
Fewer Drug Approvals? Buy! Stricter standards at the FDA could create a buying opportunity. Drug approvals are down one third this year, creating a lot of value in pharmaceutical and biotech companies. Just choose your medicines carefully. |
Outside
February 2005 |
Globe-Trekking Gear Myopic adventurers, rejoice... Javelin... Samsung SCH-S250... |
The Motley Fool
May 8, 2009
Brian Orelli |
Investing Against Breast Cancer Many companies are interested in both a cure and a large lucrative market. Which are the best investments now in this sector? |
